Guardant Health exchanges $659.3M of 0% 2027 notes for $600M of 1.25% 2031 notes; plans $45M buyback

Guardant Health, Inc.

Issues $600M of 1.25% Convertible Senior Notes due Feb 15, 2031, exchanging for $659.3M of 0% Convertible 2027 Notes.
Initial conversion price of new notes ~$62.22/share, a 35% premium to Feb 6, 2025 closing price.
After close (~Feb 14, 2025), $490.7M of 2027 Notes remain outstanding with unchanged terms.
Intends to repurchase ~$45M of common stock from participants; exchange agent will buy ~$35M separately.
New notes are unregistered, issued under Section 4(a)(2) and 3(a)(9) exemptions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.